Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | -6.98% | +8.11% | +63.27% |
May. 22 | Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial | MT |
May. 14 | Optimi Health Receives Certificate of Analysis for Mdma 40Mg and 60Mg Gmp Capsules | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+63.27% | 28.55M | |
-.--% | 843M | |
+3.15% | 704M | |
+31.19% | 479M | |
+26.85% | 252M | |
0.00% | 135M | |
+113.04% | 59.39M |
- Stock Market
- Equities
- OPTI Stock
- News Optimi Health Corp.
- Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University